1. Introduction {#sec1}
===============

Cisplatin is a prominent and most potent anticancer drugs and it used to treat metastatic testicular and ovarian cancer [@bib1]. It is also used for treatment on various type cancer like lung, urine bladder, head, neck, esophageal, stomach, skin prostate, lymphoma and neuroblastoma, sarcoma, cervical, myeloma, mesothelima and osteosarcoma. In spite of its significant anticancer activity, cisplatin is often dose limited undesirable side effects such as nephrotoxicity [@bib2]. Recent studies has been reported that nephrotoxicity and hepatotoxicity are cisplatin induced is reported that cisplatin and others around the world suggested hepatotoxicity is also a major dose-limiting side effect in cisplatin-based chemotherapy \[[@bib3], [@bib4], [@bib5], [@bib6]\]. Cisplatin can induce heptotoxicity after administered at high doses \[[@bib7], [@bib8]\]. Metallothionein protects against liver injury induced by high doses of cisplatin in mice [@bib9]. Selenium and high dose of vitamin E administration protect against cisplatin-induced oxidative damage to liver [@bib10]. Komdeur et al (2007) has been reported that Cisplatin-induced hyperglycemic hyperosmolar coma [@bib11]. Amin et al (2007) has well documented that effect of Roselle and Ginger on cisplatin-induced reproductive toxicity in rats [@bib12].

With this background, the present study has designed to investigate whether have any effect of cisplatin on pancreas and testes in Wistar rats.

2. Materials and methods {#sec2}
========================

2.1. Drug and reagents {#sec2.1}
----------------------

5,5-dithiobis 2-nitrobenzoic acid (Merck pvt. Ltd., India). Thiobarbuturic acid (Loba chemicals pvt.ltd. India). Superoxide Dismutase (sigma Aldrich chemicals pvt. Ltd. India).

2.2. Animals {#sec2.2}
------------

The Wistar rats were allowed to have an access to water and food ad libitum, and maintained under constant (25 ± 1 °C), humidity (65 ± 10 %) and a 12 h light/dark cycle. The experiment was carried out in accordance to the guidelines mentioned in the CPCSEA, and institution animal ethical committee of Sumandeep Vidyapeeth University was approved the experiment protocols. The experiment was conducted in accordance with accepted standard guidelines for the care and use of animals in scientific research.

2.3. Cisplatin-induced toxicity {#sec2.3}
-------------------------------

Two groups of rats (n = 6) used, in which 1^st^ group administered 5 ml/kg normal saline throughout the experiment for 7 days; 2^nd^ group (cisplatin treated) with single dose of cisplatin (10 mg/kg i.p.) on 1^st^ day and keep animals up to 7 days. On the 7^th^ day all animals were anaesthetized with diethyl ether. Blood sample (1--1.5 ml) was collected at once from the retro orbital plexus of rats under light diethyl ether anaesthesia, for biochemical parameter estimation. Pancreas and testes were subjected to histopathological study.

2.4. Biochemical analysis {#sec2.4}
-------------------------

### 2.4.1. Determination blood glucose level {#sec2.4.1}

The Blood glucose was determined by the method of O-toluidine using the modified reagent [@bib13] and Glycosylated hemoglobin (gly Hb) was determined by the method of Sudhakar and Pattabiraman [@bib14].

### 2.4.2. Determination reduced glutathione (GSH) {#sec2.4.2}

GSH Levels in pancreas and testis were estimated by the method (Beutler et al. 1963). 10% (w/v) homogenate prepared by added 5% trichloroacetic acid solution. It was centrifuged at 3500 rpm for 10 min, 50 μL supernatant was mixed with 0.32 mol/L disodium hydrogen phosphate and 0.04% 5,5-dithiobis 2-nitrobenzoic acid (DTNB) solution. The yellow-colored substance formed by the reaction of GSH and DTNB was measured at 412 nm. The results were expressed as GSH mg/g tissue weight [@bib15].

### 2.4.3. Determination of malondialdehyde (MDA) {#sec2.4.3}

MDA levels were estimated by the method of (Satoh 1978). 10% (weight/volume) homogenate of pancreas and testis was prepared by added 0.1 mol/L phosphate buffer. It was centrifuged at 4 °C, 3500 rpm for 10 min. 0.2 mL supernatant was mixed with 0.67% 2-thiobarbuturic acid (TBA) and 20% trichloroacetic acid solution, and heated in a boiling water bath for 30 min. The pink-coloured chromogen formed by the reaction of TBA with MDA was measured at 532 nm. The results were expressed as MDA nmol/mg protein [@bib16].

### 2.4.4. Determination of superoxide dismutase (SOD) {#sec2.4.4}

Superoxide dismutase (SOD) activity in pancreas and testis homogenate was determined according to the method (Minami and Yoshikawa 1979). The homogenate was centrifuged at 2500 rpm for 15 minutes at 4 °C. The 0.25 ml of supernatant was mixed with 0.5 ml of tris cacodylic buffer, and 0.1 ml of 16% triton x- 100 and 0.25 ml NBT. The reaction was started by the addition of 0.01 ml diluted pyrogallol. It was kept on Incubation for 5 minutes at 37 °C. The reaction was stopped by the addition of 0.3 ml of 2 M formic acid. The formazan colour developed was determined spectrophotometrically (Spectronic 501, Shimadzu). Enzymatic activity (SOD) was expressed as U/g of tissue [@bib17].

2.5. Histopathological examination {#sec2.5}
----------------------------------

The Wistar rats were sacrificed on the day of blood withdrawal. Pancreas and testis were isolated, processed, and embedded in paraffin wax. The sections were stained in haematoxylin and eosin and permanently mount for viewing and reporting [@bib18].

2.6. Statistical analysis {#sec2.6}
-------------------------

Result were expressed as mean +SEM, Statistical Analysis were performed with unpaired t test. P value less than\<0.05 was considered.

3. Results {#sec3}
==========

3.1. Changes of body weight of rats {#sec3.1}
-----------------------------------

Cisplatin treated group showed significantly (*p \< 0.001*) decreased body wt of rats as compared control group ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1Effect of Cisplatin after 6th day on body weight (gm) of rats. Each group represents mean ± SD of six animals as compared to control treated group. \*\*p \< 0.01 as compared to the control control.Fig. 1

3.2. Alteration of biochemical parameters {#sec3.2}
-----------------------------------------

The cisplatin-treated group showed significantly (*p \< 0.001*) increased glucoses, gly Hb in blood on the 7^th^ day as compared to the control group ([Table 1](#tbl1){ref-type="table"}).Table 1Effect of cisplatin on biochemical parameters in serum.Table 1ParametersControl groupsCisplatin treated groupGlucose83.83 ± 3.71194.64 ± 2.36 \*\*\*Gly Hb5.96 ± 0.58.65 ± 0.60 \*Total protein8.56 ± 1.355.24 ± 0.86\*\*[^1]

In term of tissue homogenate biochemical estimation, it was found that the cisplatin-treated group showed significantly (*p \< 0.001*) increased lipid peroxidation ([Table 2](#tbl2){ref-type="table"}), whereas significantly (*p \< 0.001*) decreased GSH, SOD, CAT in pancreatic and testicular tissue (Tables [2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}) as compared to the control group.Table 2Levels of GSH, SOD, CAT and MDH in pancreatic tissues of control and cisplatin treated group of rats.Table 2ParametersControl groupCisplatin treated groupGSH(μmol/g)11.45 ± 1.357.57 ± 1.35\*\*MDH(nmol/g)24. ± .8574.84 ± 1.42\*\*SOD(U/g)15.46 ± 1.667.63 ± 1.33\*\*CAT(μmol H2O2/g)298 ± 1.84185 ± 3.45\*\*[^2]Table 3Levels of GSH, SOD, CAT and MDH in testicle tissue of control and cisplatin treated group of rats.Table 3ParametersControl groupCisplatin treated groupGSH(μmol/g)55 ± 2.4542.48 ± 2.68\*\*MDH(nmol/g)44. ±1 .6465.38 ± 2.24\*\*SOD(U/g)28.46 ± 2.2515.25 ± 2.24\*\*CAT(μmol H2O2/g)225 ± 2.54105 ± 2.34\*\*[^3]

3.3. Histopathological examination {#sec3.3}
----------------------------------

Histopathological sections of the pancreatic tissue showed marked vasoconstriction and micro infiltration were observed cisplatin treated group II \[[Fig. 2](#fig2){ref-type="fig"} Plates 1(B)\] as compared to control group \[[Fig. 2](#fig2){ref-type="fig"} Plates 1(A)\].Fig. 2Plate 1(A) Photograph of Pancreas in control group rat, Plate 1(B) Photograph of pancreas Cisplatin treated rat. Plate 1(C) Photograph of testis in control group rat. Plate 1 (D) Photograph of testes in cisplatin treated rat.Fig. 2

Histopathological sections of testicular tissue showed degeneration in some somniferous tubules and were also greatly depleted of germ cells in cisplatin treated group II \[[Fig. 2](#fig2){ref-type="fig"} Plates 1(D)\] as compared to control group \[[Fig. 2](#fig2){ref-type="fig"} Plates 1(C)\].

4. Discussion {#sec4}
=============

The present study to investigate the effect of cisplatin on body wt of rats, biochemical parameters and histology of pancreas and testes.

After single dose of 10 mg/kg the cisplatin-treated showed a significant decreased body wt of rats as compared control group. The loss body wt of rats due to cisplatin induced gastrointestinal toxicity. Shahid et al (2018) has been reported that cisplatin induced gastrointestinal dysfunction due to concurrently utilized cisplatin with plant-derived agents [@bib19].

After single dose of 10 mg/kg the cisplatin-treated showed a significant increase glucoses and gly Hb in serum me be due their emetogenic, glucocorticoids effect. The glucocorticod induces diabetes via impaired glucose metabolism.

In the present study, Cisplatin treated groups showed significantly increased lipid peroxidation and GSH, SOD, CAT were significantly decreased in pancreatic and testicular tissue as compared control group. The instantaneously significant decrease of antioxidants enzyme in cisplatin-induced tissues could potentiate elucidates the upregulation of lipid peroxidation [@bib20]. It has been also well documented about a relationship between cisplatin-induced complications and lipid peroxidation [@bib21]. Actually, cisplatin reacts with water and generated free radical. It\'s free radical oxidative stress induced toxicity pancreatic and testicular tissue ([Fig. 3](#fig3){ref-type="fig"}).Fig. 3Mechanism of cisplatin induces pancreatic and testicle toxicity.Fig. 3

There are many previous studies have been well documented that cisplatin induces toxicity in liver [@bib22] kidney \[[@bib23], [@bib24]\], due their free radical oxidative stress by interacting with DNA [@bib25].

*In vitro and in vivo* Previous studies reported that cisplatin induces apoptotic cell death at low dose and it produces both necrosis and apoptosis at higher dose \[[@bib26], [@bib27]\]. There are numerous apoptotic pathways which are mediated by TNF receptors as an extrinsic pathway and the mitochondrial and endothelium stress as an intrinsic pathway [@bib28].

Histopathological sections of the pancreatic tissue showed marked vasoconstriction and micro infiltration which was indicates cisplatin could be indicated diabetes. It was also suggested by Goldstein et al [@bib29], Nan et al (2003) and Komdeur et al [@bib30].

Histopathological sections of testicular tissue showed degeneration in some somniferous tubules and were also greatly depleted of germ cells in cisplatin treated could be showed testicular toxicity. The present study is supported by Amr et al (2006) which are reported as effects of Roselle and Ginger on cisplatin-induced reproductive toxicity in rats [@bib31].

Hence, cisplatin-induced pancreas and testicular damage due to their free radical mediated oxidative necrosis of tissue.

5. Conclusion {#sec5}
=============

Finally on the basis of these investigations, it is concluded that cisplatin could be induced diabetes and testicular toxicity due to their cytotoxic and sever free radical oxidative stress effect. Actually, Cisplatin induces toxicity due their free radical oxidative stress by interacting with DNA. Further more studies needed for next generation.
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[^1]: \*\*\*P \< 0.01, \*\*P \< 0.01 and \*P \< 0.05 as compared to the Control.

[^2]: \*\*P \< 0.01 as compared to the Control.

[^3]: \*\*P \< 0.01 as compared to the Control.
